{
  "id": 17060464,
  "title": "Ace Blend bags $9.91M as it looks to scale science-led nutrition",
  "url": "https://urgent.news/2026/10/29/ace-blend-bags-9-91m-as-it-looks-to-scale-science-led-nutrition",
  "topic": "business",
  "section": "Business",
  "published": "2026-10-29T12:18:20.000Z",
  "source": {
    "name": "YourStory",
    "slug": "yourstory",
    "url": "https://yourstory.com/2026/10/ace-blend-bags-991m-as-it-looks-to-scale-science-led-nutrition"
  },
  "original_language": "en",
  "account": "Ace Blend, a science-driven nutrition company, has secured $9.91 million in a Series A2 funding round led by venture capital firm 3one4 Capital. Pre-existing investor Fireside Ventures increased its stake after backing the company's $3.3 million pre-Series A round. The additional capital will fuel research-based product development and the commercial launch of proprietary nutrition formats, with the first products anticipated in the fourth quarter of the current fiscal year. Established in 2018 following a decade of research, Ace Blend develops supplements aimed at heart health, immunity, sleep, recovery, and brain health. Co-founder Saif Mehkri joined the company in 2022, bringing more than two decades of experience in the nutrition sector. The firm emphasizes clinical evidence as the foundation of its approach, using research to determine a nutrient's form, dose, and delivery rather than constructing products around popular ingredients. Ace Blend also manages its own sourcing, formulation, and manufacturing processes, with clinical validation and automated testing performed by accredited laboratories in Europe. The company has formed partnerships with ingredient suppliers DSM and TCI, granting it exclusive rights in India to certain technologies. In its fiscal year 26, Ace Blend experienced a 300% growth rate, with over 46% of its customers returning to make repeat purchases. Fireside Ventures principal Ankita Balotia attributed this success to consumer trust, citing repeat purchases and word-of-mouth recommendations. However, she noted that repeat buying alone does not independently confirm a supplement's clinical effectiveness. 3one4 Capital managing partner Pranav Pai emphasized that the company is addressing some of the most challenging issues in the field of nutrition, such as creating formulations tailored to Indian requirements and maintaining consistent quality. The funding announcement arrives amidst a surge of investment activity in India's nutrition sector. In June, TruNativ raised $30 million led by healthcare investment firm OrbiMed. Earlier this month, supplement brand Supply6 secured Rs 48 crore from Unilever Ventures and Zeropearl VC. Most recently, The Stack raised Rs 21.5 crore in October to bolster its research capabilities and product portfolio. These investments highlight growing investor interest in differentiated formulations, product innovation, and repeat demand in a highly competitive market. Regulation remains a critical consideration as brands increasingly make specific health claims. The Food Safety and Standards Authority of India oversees health supplements and nutraceuticals, alongside distinct rules governing advertising and claims. In February, the Indian government announced the absence of a dedicated Ministry of Food Processing Industries scheme for nutraceuticals, although broader food-processing programs aim to support infrastructure development.",
  "summary": "The nutrition company will use the funding to advance research-led product development and launch patented nutrition formats.",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}